| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $1.7M | -27.2% | +65.1% |
| SG&A Expense | $1.6M | -68.7% | -4.9% |
| Operating Income | -$3.3M | +55.6% | -21.7% |
| Pre-tax Income | -$3.3M | +56.2% | -20.2% |
| Income Tax | $0 | — | — |
| Net Income | -$3.3M | +56.2% | -20.2% |
| EPS (Basic) | -$0.36 | +73.9% | +75.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.9M | +32.9% | -16.0% |
| Current Assets | $10.2M | +29.1% | -14.6% |
| Total Assets | $10.2M | +28.7% | -14.6% |
| Current Liabilities | $1.6M | +11.0% | -26.5% |
| Total Liabilities | $1.6M | +11.0% | -26.5% |
| Stockholders' Equity | $8.6M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.4M | — | — |
| Capital Expenditures | $7K | — | — |
| Investing Cash Flow | -$7K | — | — |
| Financing Cash Flow | $10.2M | — | — |
| Free Cash Flow | -$9.4M | — | — |
| -11.8% |